Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -100.00% vs 37.50% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -3.28% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -6.87% vs -6.43% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is -1.67% vs -1.64% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 8.49% vs 15.18% in Mar 2024
Compare Balance Sheet Results of Emmessar Biotech
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
4.20
0.80
19.05%
Share Warrants & Outstandings
Total Reserve
2.71
10.09
-7.38
-73.14%
Shareholder's Funds
7.71
14.29
-6.58
-46.05%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.32
0.09
0.23
255.56%
Other Long Term Liabilities
0.59
0.00
0.59
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.13
0.00
0.13
0.00%
Total Non-Current Liabilities
1.04
0.09
0.95
1,055.56%
Current Liabilities
Trade Payables
0.00
0.21
-0.21
-100.00%
Other Current Liabilities
0.13
0.44
-0.31
-70.45%
Short Term Borrowings
0.00
2.23
-2.23
-100.00%
Short Term Provisions
0.34
0.00
0.34
0.00%
Total Current Liabilities
0.47
2.88
-2.41
-83.68%
Total Liabilities
9.22
17.27
-8.05
-46.61%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.04
15.78
-13.74
-87.07%
Less: Accumulated Depreciation
0.82
9.90
-9.08
-91.72%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.22
5.88
-4.66
-79.25%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.14
-0.14
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.59
2.14
-1.55
-72.43%
Long Term Loans & Advances
0.00
0.08
-0.08
-100.00%
Other Non Current Assets
0.00
0.37
-0.37
-100.00%
Total Non-Current Assets
1.81
8.61
-6.80
-78.98%
Current Assets Loans & Advances
Current Investments
0.01
0.00
0.01
0.00%
Inventories
0.12
3.75
-3.63
-96.80%
Sundry Debtors
0.02
4.55
-4.53
-99.56%
Cash and Bank
6.87
0.08
6.79
8,487.50%
Other Current Assets
0.09
0.11
-0.02
-18.18%
Short Term Loans and Advances
0.29
0.17
0.12
70.59%
Total Current Assets
7.41
8.65
-1.24
-14.34%
Net Current Assets (Including Current Investments)
6.93
5.77
1.16
20.10%
Total Current Assets Excluding Current Investments
7.40
8.65
-1.25
-14.45%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.22
17.27
-8.05
-46.61%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
2.23
-2.23
-100.00%
Book Value per share (adjusted)
15.43
34.03
-18.60
-54.66%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 37.50% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.28% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 1.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.87% vs -6.43% in Mar 2024
Annual - Investments
Investments 0.59 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.67% vs -1.64% in Mar 2024
Annual - Current Assets
Current Assets 7.41 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.49% vs 15.18% in Mar 2024






